Search research articles
Contact Us
Filters
Showing results (121-130 of 149) with videos related to
Page
of 15
Sort By:
Inflammatory Bowel Diseases
|
August 23, 2001
Mesalazine 4 g daily given as prolonged-release granules twice daily and four times daily is at least as effective as prolonged-release tablets four times daily in patients with ulcerative colitis
P G Farup, T A Hinterleitner, M Lukás, et al.
Alimentary Pharmacology & Therapeutics
|
May 26, 2010
Potential role of the cannabinoid receptor CB in the pathogenesis of erosive and non-erosive gastro-oesophageal reflux disease
C Calabrese, E Spisni, G Liguori, et al.
Alimentary Pharmacology & Therapeutics
|
February 27, 2008
Short-term treatment with infliximab in chronic refractory pouchitis and ileitis
C Calabrese, P Gionchetti, F Rizzello, et al.
Diseases of the Colon and Rectum
|
February 1, 1986
Retrograde spread of 5-aminosalicylic acid enemas in patients with active ulcerative colitis
M Campieri, G A Lanfranchi, C Brignola, et al.
Neurogastroenterology and Motility
|
June 1, 2017
Stress and brain functional changes in patients with Crohn's disease: A functional magnetic resonance imaging study
A Agostini, D Ballotta, S Righi, et al.
Cancer Research
|
February 15, 1990
Rectal cell proliferation and colon cancer risk in ulcerative colitis
G Biasco, G M Paganelli, M Miglioli, et al.
British Journal of Cancer
|
August 19, 2010
Selective cyclooxygenase-2 silencing mediated by engineered E. coli and RNA interference induces anti-tumour effects in human colon cancer cells
A Strillacci, C Griffoni, G Lazzarini, et al.
International Journal of Colorectal Disease
|
November 30, 2002
The effect of transient intestinal ischemia on inflammatory parameters
K M Lammers, G Innocenti, A Venturi, et al.
Alimentary Pharmacology & Therapeutics
|
August 19, 2011
Distinct proteomic profiles characterise non-erosive from erosive reflux disease
C Calabrese, V Marzano, A Urbani, et al.
Alimentary Pharmacology & Therapeutics
|
January 10, 2001
Oral versus combination mesalazine therapy in active ulcerative colitis: a double-blind, double-dummy, randomized multicentre study
M Vecchi, G Meucci, P Gionchetti, et al.
Page
of 15
Search research articles
Search
Showing results (121-130 of 149) with videos related to
Sort By:
Page
of 15
Inflammatory Bowel Diseases
|
August 23, 2001
Mesalazine 4 g daily given as prolonged-release granules twice daily and four times daily is at least as effective as prolonged-release tablets four times daily in patients with ulcerative colitis
P G Farup, T A Hinterleitner, M Lukás, et al.
Alimentary Pharmacology & Therapeutics
|
May 26, 2010
Potential role of the cannabinoid receptor CB in the pathogenesis of erosive and non-erosive gastro-oesophageal reflux disease
C Calabrese, E Spisni, G Liguori, et al.
Alimentary Pharmacology & Therapeutics
|
February 27, 2008
Short-term treatment with infliximab in chronic refractory pouchitis and ileitis
C Calabrese, P Gionchetti, F Rizzello, et al.
Diseases of the Colon and Rectum
|
February 1, 1986
Retrograde spread of 5-aminosalicylic acid enemas in patients with active ulcerative colitis
M Campieri, G A Lanfranchi, C Brignola, et al.
Neurogastroenterology and Motility
|
June 1, 2017
Stress and brain functional changes in patients with Crohn's disease: A functional magnetic resonance imaging study
A Agostini, D Ballotta, S Righi, et al.
Cancer Research
|
February 15, 1990
Rectal cell proliferation and colon cancer risk in ulcerative colitis
G Biasco, G M Paganelli, M Miglioli, et al.
British Journal of Cancer
|
August 19, 2010
Selective cyclooxygenase-2 silencing mediated by engineered E. coli and RNA interference induces anti-tumour effects in human colon cancer cells
A Strillacci, C Griffoni, G Lazzarini, et al.
International Journal of Colorectal Disease
|
November 30, 2002
The effect of transient intestinal ischemia on inflammatory parameters
K M Lammers, G Innocenti, A Venturi, et al.
Alimentary Pharmacology & Therapeutics
|
August 19, 2011
Distinct proteomic profiles characterise non-erosive from erosive reflux disease
C Calabrese, V Marzano, A Urbani, et al.
Alimentary Pharmacology & Therapeutics
|
January 10, 2001
Oral versus combination mesalazine therapy in active ulcerative colitis: a double-blind, double-dummy, randomized multicentre study
M Vecchi, G Meucci, P Gionchetti, et al.
Page
of 15